NEWS
View All- 2024.03.21 EPS Group EPNextS Group will collaborate with Frontage Laboratories, Inc. for Early Phase Clinical Trial and Clinical Site Management in the United States to Improve “Drug Lag” and “Drug Loss” Issues in Japan.
- 2023.09.04 IR EPS Group Overview of Results for the 32nd Fiscal Year Ended September 30, 2022
- 2023.07.06 EPS Group EPS Supported Important Japan-led International Investigator-Initiated HR+/HER2- Breast Cancer Study in Asia Pacific
- 2023.06.28 IR Notice regarding acquisition of R&E Corporate Ltd (HK) and Taiga Supply Chain Management (Shenzhen) Co., Ltd. by EPS Creative Health Technology Group Limited
- 2023.04.27 News Notice of EPS Group exhibiting at DIA2023 Global Annual Meeting and information about the promotional codes